A large cardiovascular outcome trial in high-risk T2D patients treated with the GLP-1 analog liraglutide (LEADER) demonstrated impressive reductions in CV mortality (22%
Mount Sinai Hospital has received funding for investigator-initiated preclinical studies from Novo Nordisk and Pfizer
It is the only biologically active form in humans
Angelie Chua, a board-certified dermatologist who shared insights on the effectiveness, safety, and proper use of skin whitening supplements
The majority of studies measured total, free and acylcarnitine levels, except for Ascha et al
Additionally, GLP-2 increases the barrier function of the gut epithelium and regulates gastric motility, gastric acid secretion, and intestinal hexose transport [66, 67]